BioCentury | Jul 12, 2019
Financial News

HitGen joins growing Shanghai IPO queue

...and research institutes, as reflected by its deal with Adam Zhao’s Anlong Fund to form NetVation DL Medicine...
...Histone deacetylase 1; HDAC2 - Histone deacetylase 2 Hongjiang Li, Staff Writer HG146 Almirall S.A. Gilead Sciences Inc. HitGen Ltd. NetVation DL Medicine Nuevolution...
BioCentury | Jun 29, 2019
Finance

New fund to expand Anlong’s tool kit for early stage deals

...companies at the partners’ NetVation incubator. One of the first to emerge from the incubator, NetVation DL Medicine...
...Chinese market in the future. Hongjiang Li, Staff Writer Anlong C-Bridge Capital Cash Capital HitGen Ltd. I-Mab Biopharma Laekna Therapeutics Shanghai Co. Ltd. NetVation DL Medicine Pfizer...
BioCentury | Nov 9, 2018
Tools & Techniques

HitGen’s DNA for small molecules

...VCs to set up JVs in China. This year, HitGen and Beijing-based AnlongMed Fund founded NetVation DL Medicine...
...Calif. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. NetVation DL Medicine...
BioCentury | Feb 9, 2018
Company News

NetVation, Pfizer partner for drug discovery

...Drug discovery newco NetVation DL Medicine (Chengdu, China) and Pfizer Inc. (NYSE:PFE) partnered to develop new chemical entities...
...DL Medicine CEO Wei Chen previously led drug discovery at HitGen. From 1988 to 2010, DL Medicine...
...at Tsinghua University. NetVation DL Medicine, Chengdu, China Pfizer Inc. (NYSE:PFE), New York, N.Y. Business: Pharmaceuticals Allison Johnson HitGen Ltd. NetVation DL Medicine Pfizer...
BioCentury | Feb 7, 2018
Company News

NetVation, Pfizer in drug discovery deal

...Drug discovery newco NetVation DL Medicine (Chengdu, China) and Pfizer Inc. (NYSE:PFE) partnered to develop new chemical entities...
...Inc. (NYSE:PFE) partnered to develop new chemical entities against undisclosed targets in multiple therapeutic areas. DL Medicine...
...development. DL Medicine CEO Wei Chen previously led drug discovery at HitGen. From 1988 to 2010, DL Medicine...
Items per page:
1 - 5 of 5
BioCentury | Jul 12, 2019
Financial News

HitGen joins growing Shanghai IPO queue

...and research institutes, as reflected by its deal with Adam Zhao’s Anlong Fund to form NetVation DL Medicine...
...Histone deacetylase 1; HDAC2 - Histone deacetylase 2 Hongjiang Li, Staff Writer HG146 Almirall S.A. Gilead Sciences Inc. HitGen Ltd. NetVation DL Medicine Nuevolution...
BioCentury | Jun 29, 2019
Finance

New fund to expand Anlong’s tool kit for early stage deals

...companies at the partners’ NetVation incubator. One of the first to emerge from the incubator, NetVation DL Medicine...
...Chinese market in the future. Hongjiang Li, Staff Writer Anlong C-Bridge Capital Cash Capital HitGen Ltd. I-Mab Biopharma Laekna Therapeutics Shanghai Co. Ltd. NetVation DL Medicine Pfizer...
BioCentury | Nov 9, 2018
Tools & Techniques

HitGen’s DNA for small molecules

...VCs to set up JVs in China. This year, HitGen and Beijing-based AnlongMed Fund founded NetVation DL Medicine...
...Calif. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. NetVation DL Medicine...
BioCentury | Feb 9, 2018
Company News

NetVation, Pfizer partner for drug discovery

...Drug discovery newco NetVation DL Medicine (Chengdu, China) and Pfizer Inc. (NYSE:PFE) partnered to develop new chemical entities...
...DL Medicine CEO Wei Chen previously led drug discovery at HitGen. From 1988 to 2010, DL Medicine...
...at Tsinghua University. NetVation DL Medicine, Chengdu, China Pfizer Inc. (NYSE:PFE), New York, N.Y. Business: Pharmaceuticals Allison Johnson HitGen Ltd. NetVation DL Medicine Pfizer...
BioCentury | Feb 7, 2018
Company News

NetVation, Pfizer in drug discovery deal

...Drug discovery newco NetVation DL Medicine (Chengdu, China) and Pfizer Inc. (NYSE:PFE) partnered to develop new chemical entities...
...Inc. (NYSE:PFE) partnered to develop new chemical entities against undisclosed targets in multiple therapeutic areas. DL Medicine...
...development. DL Medicine CEO Wei Chen previously led drug discovery at HitGen. From 1988 to 2010, DL Medicine...
Items per page:
1 - 5 of 5